Skip to main content

Increasing Number of Diagnosed Hemophilia Patients To Drive Bleeding Disorders Treatment Market

The report “Bleeding Disorders Treatment Market by Type Hemophilia A, Hemophilia B, vWD and others, by Drug Class – Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant and Others – Global Forecast to 2021″, report provides a detailed overview of the major drivers, restraints, threats, opportunities, current market trends, and strategies impacting the bleeding disorders treatment market along with the estimates and forecasts of the revenue and market share analysis.
Browse 36 market data Tables and 20 Figures spread through 170 Pages and in-depth TOC on “Bleeding Disorders Treatment Market by Type Hemophilia A, Hemophilia B, vWD and others, by Drug Class – Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant and Others – Global Forecast to 2021”.

Early buyers will receive 10% customization on reports.
This report studies the global bleeding disorders treatment market over the forecast period of 2016 to 2021. This market is valued at USD 10.33 Billion in 2016 and expected to grow at a CAGR of 7.9% from 2016 and 2021, to reach an estimated value of USD 15.09 Billion by 2021.


The increasing prevalence of bleeding disorders and their rising awareness are key market drivers. Government initiatives, rising R&D activities, and investments by key players are further expected to expedite the growth of bleeding disorders treatment market globally.

The report segments this market based on type, drug class, and region. The type segment is further classified into hemophilia A, hemophilia B, von Willebrand Disease (vWD), and others. The hemophilia A and B are further classified (based on disease management) as prophylaxis and on-demand. The hemophilia A segment is estimated to account for the largest share in 2015.

The drug class segment is further classified into plasma-derived coagulation factor concentrates, recombinant coagulation factor concentrates, desmopressin, antifibrinolytics, fibrin sealants, and others. The recombinant coagulation factor concentrates segment is estimated to account for the largest market share in 2015. Growth in this market is attributed to the rising R&D investments for the development and manufacturing of recombinant products by major players. Plasma-derived segment is estimated to register the slowest CAGR, owing to its reducing demand from end users due to risk of acquiring blood-associated infections. Additionally, difficulty in sourcing plasma from blood (due to scarcity of blood donors) further limits the growth of plasma-derived coagulation factor concentrates market.

Based on region, the global bleeding disorders treatment market is segmented into North America, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW). North America is estimated to contribute the largest share of the market throughout the forecast period. The market in APAC is estimated to register the highest CAGR during the forecast period, owing to increasing awareness of these disorders in the emerging economies such as India and China.

The key players operating in bleeding disorders treatment market include Shire (U.S.), CSL Behring (U.S.), Bayer AG (Germany), Novo Nordisk A/S (Denmark), Pfizer Inc. (U.S.), Biogen (U.S.), and Octapharma (Switzerland).


About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

Article Credit: Healthcare DC
Labels:

Comments

Post a Comment

Popular posts from this blog

A Best e-Commerce Platform for B2B & B2C Businesses – STORM

  Storm eCommerce platform is one of the modern, scalable, and advanced, eCommerce platforms, designed for online merchants who deal with several transactions. Smaller online retailers with rapidly growing business may also choose this product. Developed in 2008, Storm Commerce has turned out to be a useful platform with eCommerce solutions. Storm Commerce is mainly equipped with B2B functionalities, automated technologies, and user-friendly interface. USP of This Platform: Storm eCommerce platform is a seamless platform and its customized solutions can manage several deals of B2B and B2C businesses. The automation technologies have helped businesses to ensure an increased profitability, higher performance, and smarter workflows. As one of the cloud SaaS solutions, Storm is valuable for its performance and high capacity. The open APIs of Storm enable users to integrate a CMS and different other systems. It helps in developing omni-channel commerce with its features and functionalit...
1 comment
Read more

Cell Sorting Market

The global  cell sorting market  is projected to reach USD 247.4 Million by 2021, at a CAGR of 7.0% in the forecast period (2016-2021). Factors such as technological advancements in cell sorters, rising funding and investments for development of technologically advanced cell sorters, and growing adoption of cell sorting techniques in research activities are driving the growth of global Market. The market is further driven by factors such as the growing prevalence of HIV/AIDS and cancer, expanding pharmaceutical and biotechnology industries, and launch of specific reagents for specific applications. However, factors such as the high cost of instruments and lack of awareness & technical knowledge regarding the use of cell sorters are hampering the growth of market. Geographically, the market is segmented into North America, Europe, Asia-Pacific, and RoW. Among the four geographic regions, North America is estimated to command the largest share of the market in 2016, foll...
Post a Comment
Read more

Diagnostic Catheter Market: What Will be the Growth Scenario in the next five years?

 The overall diagnostic catheters market is projected to reach USD 4,302.3 million by 2021 from USD 3,025.8 million in 2016, at a CAGR of 7.3% from 2016 to 2021. Advancements in medical imaging technologies, increasing number of minimally invasive procedures, launch of new technologies in terms of catheter design, and rising geriatric population (resulting in a subsequent growth in the prevalence of chronic disorders) are primarily expected to drive growth in the global market. However, factors such as dearth of skilled professionals, high cost of technologically advanced catheters, and the trend of reusing single-use diagnostic catheters are expected to restrain market growth to a certain extent. Growing preference of OCT imaging catheters in intravascular diagnostics and imaging: OCT has revolutionized the medical imaging industry and has extended its applications in disease diagnosis and imaging of various cellular and molecular processes in vivo. The success...
Post a Comment
Read more